亿帆医药：全资子公司参与全国药品集中采购拟中选

Core Viewpoint - Yifan Pharmaceutical (002019) announced participation in the 11th national centralized drug procurement organized by the National Organization for Drug Procurement Office, with some products expected to be selected for this procurement [1] Group 1 - Yifan Pharmaceutical's wholly-owned subsidiary, Hefei Yifan Biopharmaceutical Co., Ltd., is involved in the bidding process for the centralized procurement [1] - The products involved in the bidding include Adrenaline Hydrochloride Injection and Meprobamate Injection, which are intended to be selected in this round of procurement [1]